NCT02750722View on ClinicalTrials.gov

Exercise and Oscillatory Positive Expiratory Pressure Therapy in Cystic Fibrosis

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

January 19, 2017

Study Completion Date

January 19, 2017

Conditions
Cystic Fibrosis
Interventions
DEVICE

Flutter®

Acute exercise with Flutter® breathing therapy.

DEVICE

No Flutter®

Acute exercise without Flutter® breathing therapy.

Trial Locations (3)

8001

University of Zurich, Zurich

8091

University Hospital Zurich, Zurich

8092

ETH Zurich, Zurich

All Listed Sponsors
lead

University of Zurich

OTHER

NCT02750722 - Exercise and Oscillatory Positive Expiratory Pressure Therapy in Cystic Fibrosis | Biotech Hunter | Biotech Hunter